Cellular and Molecular Mechanisms Underlying Liver Fibrosis Regression

被引:217
作者
Caligiuri, Alessandra [1 ]
Gentilini, Alessandra [1 ]
Pastore, Mirella [1 ]
Gitto, Stefano [1 ]
Marra, Fabio [1 ]
机构
[1] Univ Florence, Dept Expt & Clin Med, I-50137 Florence, Italy
关键词
liver fibrosis; fibrosis regression; myofibroblasts; HSCs; ECM degradation; therapies; HEPATIC STELLATE-CELLS; MESENCHYMAL STEM-CELLS; SUSTAINED VIROLOGICAL RESPONSE; HISTONE DEACETYLASE INHIBITOR; SCAR-ASSOCIATED MACROPHAGES; KILLER T-CELLS; NONALCOHOLIC STEATOHEPATITIS; PORTAL-HYPERTENSION; GENE-EXPRESSION; NATURAL-KILLER;
D O I
10.3390/cells10102759
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Chronic liver injury of different etiologies may result in hepatic fibrosis, a scar formation process consisting in altered deposition of extracellular matrix. Progression of fibrosis can lead to impaired liver architecture and function, resulting in cirrhosis and organ failure. Although fibrosis was previous thought to be an irreversible process, recent evidence convincingly demonstrated resolution of fibrosis in different organs when the cause of injury is removed. In the liver, due to its high regenerative ability, the extent of fibrosis regression and reversion to normal architecture is higher than in other tissues, even in advanced disease. The mechanisms of liver fibrosis resolution can be recapitulated in the following main points: removal of injurious factors causing chronic hepatic damage, elimination, or inactivation of myofibroblasts (through various cell fates, including apoptosis, senescence, and reprogramming), inactivation of inflammatory response and induction of anti-inflammatory/restorative pathways, and degradation of extracellular matrix. In this review, we will discuss the major cellular and molecular mechanisms underlying the regression of fibrosis/cirrhosis and the potential therapeutic approaches aimed at reversing the fibrogenic process.</p>
引用
收藏
页数:26
相关论文
共 246 条
[1]   Hepatitis C Guidance 2019 Update: American Association for the Study of Liver Diseases-Infectious Diseases Society of America Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection [J].
Ghany M.G. ;
Morgan T.R. .
HEPATOLOGY, 2020, 71 (02) :686-721
[2]   Cellular Mechanisms of Liver Fibrosis [J].
Acharya, Pragyan ;
Chouhan, Komal ;
Weiskirchen, Sabine ;
Weiskirchen, Ralf .
FRONTIERS IN PHARMACOLOGY, 2021, 12
[3]   The Role of Cancer-Associated Fibroblasts and Fibrosis in Liver Cancer [J].
Affo, Silvia ;
Yu, Le-Xing ;
Schwabe, Robert F. .
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 12, 2017, 12 :153-186
[4]   The Human Amnion Epithelial Cell Secretome Decreases Hepatic Fibrosis in Mice with Chronic Liver Fibrosis [J].
Alhomrani, Majid ;
Correia, Jeanne ;
Zavou, Marcus ;
Leaw, Bryan ;
Kuk, Nathan ;
Xu, Rong ;
Saad, Mohamed I. ;
Hodge, Alexander ;
Greening, David W. ;
Lim, Rebecca ;
Sievert, William .
FRONTIERS IN PHARMACOLOGY, 2017, 8
[5]   A Histologic Scoring System for Prognosis of Patients With Alcoholic Hepatitis [J].
Altamirano, Jose ;
Miquel, Rosa ;
Katoonizadeh, Aezam ;
Abraldes, Juan G. ;
Duarte-Rojo, Andres ;
Louvet, Alexandre ;
Augustin, Salvador ;
Mookerjee, Rajeshwar P. ;
Michelena, Javier ;
Smyrk, Thomas C. ;
Buob, David ;
Leteurtre, Emmanuelle ;
Rincon, Diego ;
Ruiz, Pablo ;
Garcia-Pagan, Juan Carlos ;
Guerrero-Marquez, Carmen ;
Jones, Patricia D. ;
Barritt, A. Sidney ;
Arroyo, Vicente ;
Bruguera, Miquel ;
Banares, Rafael ;
Gines, Pere ;
Caballeria, Juan ;
Roskams, Tania ;
Nevens, Frederik ;
Jalan, Rajiv ;
Mathurin, Philippe ;
Shah, Vijay H. ;
Bataller, Ramon .
GASTROENTEROLOGY, 2014, 146 (05) :1231-+
[6]   Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort [J].
Anstee, Quentin M. ;
Darlay, Rebecca ;
Cockell, Simon ;
Meroni, Marica ;
Govaere, Olivier ;
Tiniakos, Dina ;
Burt, Alastair D. ;
Bedossa, Pierre ;
Palmer, Jeremy ;
Liu, Yang-Lin ;
Aithal, Guruprasad P. ;
Allison, Michael ;
Yki-Jarvinen, Hannele ;
Vacca, Michele ;
Dufour, Jean-Francois ;
Invernizzi, Pietro ;
Prati, Daniele ;
Ekstedt, Mattias ;
Kechagias, Stergios ;
Francque, Sven ;
Petta, Salvatore ;
Bugianesi, Elisabetta ;
Clement, Karine ;
Ratziu, Vlad ;
Schattenberg, Joern M. ;
Valenti, Luca ;
Day, Christopher P. ;
Cordell, Heather J. ;
Daly, Ann K. .
JOURNAL OF HEPATOLOGY, 2020, 73 (03) :505-515
[7]   Pharmacological inhibition of the chemokine CCL2 (MCP-1) diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injury [J].
Baeck, Christer ;
Wehr, Alexander ;
Karlmark, Karlin Raja ;
Heymann, Felix ;
Vucur, Mihael ;
Gassler, Nikolaus ;
Huss, Sebastian ;
Klussmann, Sven ;
Eulberg, Dirk ;
Luedde, Tom ;
Trautwein, Christian ;
Tacke, Frank .
GUT, 2012, 61 (03) :416-426
[8]   The Role of Fibrosis and Liver-Associated Fibroblasts in the Pathogenesis of Hepatocellular Carcinoma [J].
Baglieri, Jacopo ;
Brenner, David A. ;
Kisseleva, Tatiana .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (07)
[9]   Costunolide reduces glycolysis-associated activation of hepatic stellate cells via inhibition of hexokinase-2 [J].
Ban, Dujing ;
Hua, Shangbo ;
Zhang, Wen ;
Shen, Chao ;
Miao, Xuehua ;
Liu, Wensheng .
CELLULAR & MOLECULAR BIOLOGY LETTERS, 2019, 24 (01)
[10]   Efficacy of cilostazol on platelet reactivity and cardiovascular outcomes in patients undergoing percutaneous coronary intervention: insights from a meta-analysis of randomised trials [J].
Bangalore, Sripal ;
Singh, Amita ;
Toklu, Bora ;
DiNicolantonio, James J. ;
Croce, Kevin ;
Feit, Frederick ;
Bhatt, Deepak L. .
OPEN HEART, 2014, 1 (01)